FDA Alerts and Recalls
The mandatory FDA scan found materially active notices. Device entries are early alerts—not confirmed Class I recalls—and the sprouts action is an outbreak advisory/investigation rather than an interchangeable recall classification.
What changed
FDA’s most recent material postings were August 21 device early alerts and an outbreak update linking alfalfa sprouts to illnesses. Product identifiers: Medline breathing circuit, GE HealthCare Portrait Mobile monitoring software, Medical Action Industries epidural kit, and Everything Sprouts LLC alfalfa sprouts; lot, serial, model, expiration, distribution geography, recall class, confirmed injury/death counts and denominators were not reported in the accessible index records. Device status: Early Alert—FDA collecting information. Sprout status: active outbreak investigation with traceback, inspection and sampling. Recommended action: follow the linked FDA/company instructions and do not use or consume affected products where FDA identifies them. Regulatory basis: FDA safety communication, recall oversight and foodborne-illness authorities; no FDA-mandated recall was established from the index.
Why it matters
Device failures and contaminated food can cause immediate clinical or consumer harm; early alerts are not yet classified recalls.
What to watch next
FDA page updates, enforcement classifications, firm instructions, case counts, inspection findings and recall termination status.
What we know
- FDA posted August 21 early alerts involving a Medline breathing circuit, GE HealthCare Portrait Mobile monitoring software and Medical Action Industries epidural kits.
- FDA was collecting information; these notices were not yet final recall classifications.
- FDA identified alfalfa sprouts distributed by Everything Sprouts LLC of Minneapolis as an outbreak source and initiated inspection and sampling.
- Public identifiers, confirmed harm counts and denominators were not visible in the index extracts and therefore are reported as not reported.
Material unknowns
- Final device recall classifications
- Exact affected lots/models
- Confirmed injury and death counts
- Full sprouts distribution and case denominator
U.S. strategic assessment
Critical interestPrimary FDA records establish notice status, not causation beyond FDA’s stated investigation. Clinicians and consumers should follow product-specific FDA and company instructions.
Objectives
- Rapid hazard communication
- Trace and remove affected products
- Classify recalls based on evidence
- Prevent additional harm
Strategy
- Early alerts
- Recall oversight
- Traceback, inspection and sampling
- MedWatch and enforcement reporting
Outcomes
- Three device early alerts were active.
- FDA identified and investigated sprouts as an outbreak source.
- Final classification and complete injury counts remained pending.
Risks
- Respiratory-circuit malfunction
- Monitoring-software failure
- Epidural-kit defect
- Foodborne E. coli or Salmonella illness
Sources
01Primary device notice and status source
Primary outbreak, traceback, inspection and sampling status
Firm-posted recall announcements
Classification and recall-status control
Downstream jalapeño and other major-recall context
Food and supplement safety-alert scan